$OSCR

Oscar Health (NYSE: OSCR) holder plans $4.6M share sale

Oscar Health (OSCR) shareholder Mario T. Schlosser plans to sell 150,000 Class A shares worth $4.6M under Rule 144. The sale is tied to a stock option exercise set for 08/28/2026. Schlosser has sold 789,018 shares in the past three months, totaling $50.6M. The filing was signed by Gary Redman on behalf of Fidelity Brokerage Services.

Original reporting
Published Aug 28, 2026, 6:07 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 29, 2026, 8:18 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$OSCR
Bearish
medium confidence
Mentioned
$OSCR
Relevance
6/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$OSCRBearishLow
01

Why it matters

The disclosed sale adds supply to the market and may trigger short‑term price pressure.

02

Market read

Primary insider sale news for OSCR; modest materiality.

03

What to watch

The sale is tied to a stock option exercise, not a cash need; may not reflect negative outlook.

Relevance 6/10Novelty 7/10Timing: today (08/28/2026)

Background

Form 144 is a regulatory notice for the sale of restricted securities; the filing is the first public disclosure of this transaction.

Company-level read

Ticker impact

$OSCRBearishMedium confidence
Context

Form 144 filing shows holder Mario T. Schlosser plans to sell 150,000 OSCR shares worth $4.6M today.

Expected impact

Modest downward bias in intraday price.

Evidence & confidence

Insider sale of $4.6M is material for a mid‑cap health insurer; market may react with slight sell‑off.

Market effects

May signal confidence concerns among OSCR insiders, could affect health‑tech sector sentiment.

Limited to US market where OSCR trades.

Low global relevance.

Counterpoint

Insider sales often precede price rebounds; could be a buying opportunity if fundamentals remain strong.

Key entities

  • Oscar Health, Inc.

    US‑listed health‑tech insurer (NYSE: OSCR).

  • Mario T. Schlosser

    Holder of OSCR Class A shares filing the sale.

Related articles

$OSCRHighAI 8/10

OSCR Looks 33.9% Overvalued on GF Value™ as Oscar Health Revises

Oscar Health (OSCR) revised its 2026 forecasts, raising operating earnings outlook by $100M to $600M-$800M and improving medical loss ratio guidance. Revenue guidance remains $18.7B-$19B. GF Value™ indicates OSCR is 33.9% overvalued at $32.44. The company has a strong GF Score™ of 83/100, with high growth and momentum ratings but middling profitability and valuation. Insiders have sold significantly more shares than they've bought.

$OSCRHighAI 8/10

Oscar Health boosts 2026 earnings outlook, affirms revenue

Oscar Health (OSCR) updated its 2026 earnings outlook, lowering its Medical Loss Ratio to 81.0%-82.0% and raising earnings from operations to $600M-$800M. The company reaffirmed revenue guidance of $18.7B-$19.0B and maintained SG&A expense ratio targets. The updates will be discussed at its 2026 Investor Day on September 16, 2026.

$OSCRHighAI 8/10

Oscar Health raises FY26 earnings guidance by $100 million

Oscar Health (OSCR) raised its 2026 earnings guidance by $100 million, citing improved cost controls. The company expects earnings from operations to range from $600 million to $800 million, with a medical loss ratio of 81.0% to 82.0%. Total revenue guidance remains unchanged at $18.7 billion to $19.0 billion. The stock has gained 85.57% over the past year, reaching a 52-week high of $27.59.

$CNCMed

CNC, OSCR Stocks Rally After Baird Calls Risk Adjustment Results Favorable

Centene (CNC) and Oscar Health (OSCR) shares rose 6% and 12% respectively after Baird reported favorable risk adjustment results. Baird noted the outcomes support Centene's Q4 commentary and align with Oscar's June investor conference remarks. Molina (MOH) shares also rose 2% despite a minor negative impact. The Centers for Medicare & Medicaid Services released final 2025 risk adjustment data on June 30, affecting insurers' earnings.